← Human Trials & Peer-Reviewed Studies
Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial
Plain-language guide to PMID 35883082 (2022): double-blind randomized controlled trial study of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 35883082
- Journal
- BMC women's health
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Tarkesh F et al. (4 authors)
- DOI
- 10.1186/s12905-022-01825-8
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Patients with Polycystic ovary syndrome (PCOS) are predisposed to the development of several mental comorbidities such as depression.
The insulin-sensitizing effect of vitamin K has been reported in recent studies.
Who Took Part
PubMed tags the participants as women only.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
The timeline in the abstract includes 8 weeks.
In this randomized, double blind, placebo-controlled clinical trial, depression status was measured by BECK depression inventory-II (BDI-II) before and after 8 weeks of intervention.
What Was Measured
Therefore, in the current trial, the researchers assessed the effect of administrating vitamin K2 (Menaquinone-7) on depression status in women afflicted with PCOS.
Topics PubMed links to this paper include Capsules, Depression, Dietary Supplements, Insulin, Insulin Resistance, Polycystic Ovary Syndrome and Vitamin K 2.
The authors tagged it with the keywords Vitamin K2.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc over 8 weeks.
Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2022 (BMC women's health), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.